Fed’s John Williams says rates could be increased if inflation doesn’t come down
The current problems in the banking industry and their impact will factor into Williams’ policy outlook.
This unique biotech play should rally more than 35% ahead, BTIG says
The Wall Street firm said this stock is a category leader for model-informed drug development (MIDD), or simulations for biotech drug trials.
FDA seems skeptical of push for birth control pill without a prescription
HRA Pharma asked the Food and Drug Administration to allow over-the-counter sales of Opill after the Supreme Court said there was no federal right to abortion.
GM hires ex-Apple exec to lead new software unit
Software, specifically monetizing it, is a major focus for automakers such as GM, as it eyes recurring revenue opportunities.
This solar energy tech stock could surge more than 50%, Guggenheim says
Analyst Joseph Osha upgraded Shoals’ shares to buy, citing strong first-quarter results and a higher-than-expected full-year outlook.
JPMorgan says this banking software provider can rally more than 20%
Analyst Alexei Gogolev initiated the stock with an overweight rating and a $15 price target, which implies shares gaining 21.4% from Monday’s close.
This semi stock could be in trouble as margin pressures grow, BMO says
Analyst Ambrish Srivastava lowered his rating on the stock, citing concerns regarding multiquarter headwinds to gross margins.
Wiz’s rapid ascent to $10 billion valuation in market downturn shows cloud security is ‘still huge’
Wiz is gaining traction quickly in cloud security and taking business from Palo Alto Networks, but not simply by offering lower prices.
Jefferies says this plumbing stock can rally nearly 30%, sees company increasing market share
Jefferies upgraded the stock to buy from hold. Its new price target of $181 implies shares rallying 28% from Monday’s close.
IBM takes another shot at Watson as A.I. boom picks up steam
IBM is out with WatsonX, its biggest artificial intelligence bet since the original Watson
